Status:
RECRUITING
A Pragmatic Randomized Controlled Trial to Predict Postpartum Hemorrhage
Lead Sponsor:
Holly Ende
Collaborating Sponsors:
Vanderbilt University Medical Center
Conditions:
Post Partum Hemorrhage
Eligibility:
FEMALE
Phase:
NA
Brief Summary
This research project aims to enhance the safety of childbirth by using advanced computer models to predict the risk of postpartum hemorrhage (PPH). PPH is a significant concern for mothers during an...
Detailed Description
Postpartum hemorrhage (PPH) is a common complication following vaginal or cesarean delivery and contributes significantly to maternal morbidity and mortality in the United States. There are numerous c...
Eligibility Criteria
Inclusion
- All vaginal and cesarean deliveries occurring at Vanderbilt University Medical Center
Exclusion
- All patients will be randomized at the time of admission to the obstetric service. Patients who are discharged prior to delivery will be excluded from subsequent analysis. Any patients with a pre-delivery planned hysterectomy (for placenta increta or percreta) will be excluded from the treatment algorithm and primary analysis.
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
10000 Patients enrolled
Trial Details
Trial ID
NCT06513351
Start Date
January 1 2025
End Date
July 1 2027
Last Update
October 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt University Medical Center
Nashville, Tennessee, United States, 37212